International Stem Cell (ISCO) Common Equity (2016 - 2025)
Historic Common Equity for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to -$3.8 million.
- International Stem Cell's Common Equity rose 655.78% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.8 million, marking a year-over-year increase of 655.78%. This contributed to the annual value of -$3.9 million for FY2024, which is 613.8% up from last year.
- As of Q3 2025, International Stem Cell's Common Equity stood at -$3.8 million, which was up 655.78% from -$3.9 million recorded in Q2 2025.
- Over the past 5 years, International Stem Cell's Common Equity peaked at -$3.8 million during Q3 2025, and registered a low of -$4.7 million during Q1 2021.
- In the last 5 years, International Stem Cell's Common Equity had a median value of -$4.3 million in 2024 and averaged -$4.2 million.
- In the last 5 years, International Stem Cell's Common Equity crashed by 6524.8% in 2021 and then surged by 1704.64% in 2023.
- International Stem Cell's Common Equity (Quarter) stood at -$4.6 million in 2021, then rose by 1.48% to -$4.5 million in 2022, then grew by 7.37% to -$4.2 million in 2023, then grew by 6.14% to -$3.9 million in 2024, then rose by 3.92% to -$3.8 million in 2025.
- Its Common Equity was -$3.8 million in Q3 2025, compared to -$3.9 million in Q2 2025 and -$4.1 million in Q1 2025.